Neurolutions Receives U.S. Food and Drug Administration De Novo Market Authorization for IpsiHandā¢ Upper Extremity Rehabilitation System
April 26, 2021 07:00 ET
|
Neurolutions
IpsiHand exoskeleton uniquely leverages brain-computer interface technology for chronic strokeĀ rehabilitation IpsiHand also has been granted U.S. FDA Breakthrough Device Designation SANTA CRUZ,...